Table 5: Mean (SD) fluid consumption from baseline to end of the study in patients treated with thirst-quenching lozenges.
| Fluid consumption | Mean (SD), mL | ||
| Baseline (Day 7, Visit 1) | 718.9 (178.4) | ||
| Treatment (Day 9, Visit 2) | 680.7 (214.7) | ||
| Treatment (Day 11, Visit 3) | 648.9 (196.7) | ||
| Treatment (Day 14, Visit 4) | 658.7 (239.6) | ||
| Treatment (Day 16, Visit 5) | 632.9 (229.9) | ||
| Treatment (Day 18, Visit 6) | 597.7 (235.2) | ||
| End of study (Day 21, Visit 7) | 568.1 (260.2) | ||
| Visit to visit comparison | Mean difference | 95% CI | p-value |
| Visit 2 vs. Visit 3 | -38.2 | -139.3 to 62.9 | 0.889 |
| Visit 2 vs. Visit 4 | -60.2 | -161.3 to 40.9 | 0.530 |
| Visit 2 vs. Visit 5 | -86.0 | -187.1 to 15.1 | 0.147 |
| Visit 2 vs. Visit 6 | -121.2 | -222.3 to -20.1 | 0.009a |
| Visit 2 vs. Visit 7 | -150.8 | -251.9 to -49.7 | 0.001a |
| Visit 3 vs. Visit 4 | -22.0 | -123.1 to 79.1 | 0.989 |
| Visit 3 vs. Visit 5 | -47.8 | -148.9 to 53.3 | 0.756 |
| Visit 3 vs. Visit 6 | -83.0 | -184.1 to 18.1 | 0.177 |
| Visit 3 vs. Visit 7 | -112.6 | -213.7 to -11.5 | 0.019a |
| Visit 4 vs. Visit 5 | -25.8 | -126.9 to 75.3 | 0.978 |
| Visit 4 vs. Visit 6 | -61.0 | -162.1 to 40.1 | 0.516 |
| Visit 4 vs. Visit 7 | -90.6 | -191.7 to 10.5 | 0.109 |
| Visit 5 vs. Visit 6 | -35.2 | -136.3 to 65.9 | 0.919 |
| Visit 5 vs. Visit 7 | -64.8 | -165.9 to 36.3 | 0.446 |
| Visit 6 vs. Visit 7 | -29.6 | -130.7 to 71.5 | 0.960 |
Note: aStatistically significant; CI: Confidence interval; SD: Standard deviation.